Virtus Biotech ETF BBP
94.51 USD -2.44 (-2.52%)
As ofNov 20, 2026, 3:58 PM EST
94.50 Day range 97.13
73.97 52-week range 110.05
- YTD
- +18.26%
- 1 year
- +25.48%
Virtus Biotech ETF
- Issuer
- Virtus
- Asset class
- Sector Equity
- Expense ratio
- 0.34%
- Assets under management
- $135.69M
- NAV
- 104.38
- Holdings
- 198
- Inception
- 2014-12-16
- Top 10 weight
- 28.39%
Top holdings
- MRNA Moderna Inc 6.96%
- XERS Xeris Biopharma Holdings Inc 3.02%
- VSTM Verastem Inc 2.74%
- OMER Omeros Corp 2.60%
- IOVA Iovance Biotherapeutics Inc 2.59%
- KNSA Kiniksa Pharmaceuticals International Plc 2.46%
- BGNE BeOne Medicines Ltd 2.04%
- ZLAB Zai Lab Ltd 2.03%
- ADMA ADMA Biologics Inc 2.01%
- REGN Regeneron Pharmaceuticals Inc 1.94%
- HALO Halozyme Therapeutics Inc 1.91%
- ROIV Roivant Sciences Ltd 1.75%
- EXEL Exelixis Inc 1.74%
- GILD Gilead Sciences Inc 1.74%
- ZYME Zymeworks Inc 1.74%
- AMGN Amgen Inc 1.69%
- RYTM Rhythm Pharmaceuticals Inc 1.67%
- IRWD Ironwood Pharmaceuticals Inc 1.66%
- RIGL Rigel Pharmaceuticals Inc 1.65%
- TGTX TG Therapeutics Inc 1.65%
- BIIB Biogen Inc 1.65%
- VRTX Vertex Pharmaceuticals Inc 1.60%
- PTGX Protagonist Therapeutics Inc 1.60%
- LGND Ligand Pharmaceuticals Inc 1.59%
- NVAX Novavax Inc 1.58%
Sector weights
- Healthcare 100.00%
Country weights
- United States 95.00%
- China 1.97%
- United Kingdom 1.71%
- Switzerland 1.33%
Updated 2026-11-10
